biotech and therapies

our projects

The project portfolio of Xlife Sciences AG is based on four pillars: technology platforms, biotech and therapies, medical technology and artificial intelligence. Our co-investors benefit from our unique selling proposition. In addition, our broad project portfolio offers adequate risk diversification.

alytas therapeutics GmbH

Biotech and Therapies

Alytas Therapeutics GmbH was incorporated in 2018 as a spin-off of the University of Jena and is based inJena, Germany. Its founders are experts in lipid-associated metabolic disorders and associated co-morbidities (like obesity).

Learn more

inflamed pharma GmbH

Biotech and Therapies

inflamed pharma GmbH produces, researches, develops, and manufactures the chemical and active pharmaceutical ingredients applied in innovative therapies for human and veterinary medicine.

Learn more

Lysatpharma GmbH

Biotech and Therapies

Lysatpharma focuses on regenerative medicine and new biomedical immunotherapies based on extracellular vesicles (exosomes).

Learn more

x-nuclear diagnostics GmbH

Biotech and Therapies

x-nuclear diagnostic GmbH is a spin-off of University Hospital (Universitätsklinikum) Jena founded in 2019 and based in Erfurt, Germany.

Learn more

x-kidney diagnostics GmbH

Biotech and Therapies

x-kidney diagnostics GmbH was incorporated in 2019 and is based in Erfurt, Germany. The company is dedicated to the development of new methods for the early identification of kidney diseases.

Learn more

Ix Therapeutics GmbH

Biotech and Therapies

The Ix Therapeuthics GmbH is a joint venture company founded by the Company and Indivumed GmbH in March 2021.

Learn more